Form 4 Filing for Apyx Medical Corp

Stavros G. Vizirgianakis, a director at Apyx Medical Corp, acquired 450,000 Restricted Stock Units (RSUs) on June 11, 2026. The acquisition was a grant with a transaction price of $0.0 per share. These RSUs vest over time, with 150,000 vesting immediately, and the remaining 300,000 vesting over the following two years, subject to continued service. Following this transaction, Vizirgianakis holds a total of 2,196,191 shares. This filing is a Form 4, indicating a change in beneficial ownership.